Johnson & Johnson JNJ
NYSE JNJ
$270.24 +2.87 (+1.07%)
At close: Aug 21, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Goodwill & Intangibles (2009 - 2026)

Johnson & Johnson (JNJ) posted Goodwill & Intangibles of $96.7 billion for Q2 2026, down 0.93% sequentially from $97.6 billion in Q1 2026, and down 1.27% YoY from $98.0 billion in Q2 2025.

Johnson & Johnson (JNJ) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Johnson & Johnson has reported Goodwill & Intangibles for 18 years, with the latest figure at $96.7 billion in Q2 2026.

  • Quarterly Goodwill & Intangibles fell 1.27% year-over-year to $96.7 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $96.7 billion (down 1.27% YoY) and the FY2025 annual result came in at $99.2 billion, up 21.21% from the prior year.
  • Goodwill & Intangibles fell to $96.7 billion in Q2 2026 per JNJ's latest filing, from $97.6 billion in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $99.2 billion in Q4 2025 and troughed at $70.7 billion in Q4 2023.
  • A 5-year average of $83.8 billion and a median of $81.8 billion in 2024 frame the typical range for Goodwill & Intangibles.
  • The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles surged 54.66% in 2022, then retreated 23.78% in 2024.
  • Over 5 years, Goodwill & Intangibles stood at $73.7 billion in 2022, then slipped by 4.05% to $70.7 billion in 2023, then grew by 15.67% to $81.8 billion in 2024, then increased by 21.21% to $99.2 billion in 2025, then decreased by 2.49% to $96.7 billion in 2026.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $96.7 billion, $97.6 billion, and $99.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn

Historic Data

Download Data
DateValue
Jun 28, 2026 96.71 Bn
Mar 29, 2026 97.62 Bn
Dec 28, 2025 99.18 Bn
Sep 28, 2025 96.79 Bn
Jun 29, 2025 97.95 Bn
Mar 30, 2025 81.22 Bn
Dec 29, 2024 81.82 Bn
Sep 29, 2024 84.29 Bn
Jun 30, 2024 83.98 Bn
Mar 31, 2024 70.90 Bn
Dec 31, 2023 70.73 Bn
Oct 1, 2023 71.15 Bn
Jul 2, 2023 91.69 Bn
Apr 2, 2023 93.02 Bn
Jan 1, 2023 74.54 Bn
Oct 2, 2022 73.72 Bn
Jul 3, 2022 76.57 Bn
Apr 3, 2022 79.36 Bn
Jan 2, 2022 71.83 Bn
Oct 3, 2021 83.35 Bn